News

Finnish company impressed by AI technology of AVS start-up Findest

Amsterdam Venture Studio’s startup Findest scouts technologies by using IGOR^AI. A Finnish electricity grid operator Fingrid Oyj used IGOR^AI to find out how they could increase the transmission capacity or eliminate bottlenecks. In Fingrid magazine the company shared their experience, arguing that “[IGOR^AI] is one of the first applications to really demonstrate how artificial intelligence […]

News

VU startups Digi.bio and NextRound competing to become ‘Best academic startup in the Netherlands’

Digi.bio and NextRound are selected to compete with 18 other startups by the Association of Universities in the Netherlands (VSNU), the Netherlands Academy of Technology and Innovation (AcTI) and Techleap to compete in the finals of the second edition of the Academic Startup Competition. The 20 startups were nominated from no fewer than an astounding […]

News

Introduction of LUMICKS consumables and script-sharing platform to facilitate Dynamic Single-Molecule analysis

In a move to broadly unlock Dynamic Single-Molecule (DSM) analysis, LUMICKS simultaneously launched two major initiatives: a new business line for reagents, biochemistry kits, and services, as well as its Harbor platform for sharing of DSM scripts. These new resources dramatically simplify the experimental workflow and make DSM analysis accessible across different fields and expertise […]

News

Amsterdam UMC and AlphaBiomics initiate collaboration to validate biologics treatment response predictor RxSelexTM in patients suffering from inflammatory bowel disease

This collaboration is part of 2-year UK government-funded project to bring RxSelexTM closer to patients Amsterdam UMC and AlphaBiomics Ltd., a United Kingdom (UK)-based precision medicine company, have initiated a collaboration to personalize care in patients suffering from inflammatory bowel disease (IBD). IBD patient response to biologics therapy is highly variable, with some patients receiving long-term benefits, […]

News

A story of VU startup Fitsurance

Fitsurance and how they ‘pivot’ during COVID-19, as a VU ‘personal health’ startup All was lost (well, almost) After a great pilot-project in Zeeland, where we measured runners on the beach, to see what a 3-day running event did with runners’ health,  we stepped up our efforts to prepare for 2020, in order to make […]

News

Haermonics ontvangt investering voor betere zorg na openhartchirurgie

Haermonics, een spin-off van Amsterdam UMC, heeft de effectiviteit en veiligheid bewezen van het spoelen van het hartzakje na een openhartoperatie. Een experimentele opstelling zorgde voor significant minder bloedingsgerelateerde complicaties. BOM Brabant Ventures en GAP Technologies investeren in het bedrijf voor de verdere ontwikkeling van de apparatuur en de disposables. Haermonics blijft samenwerken met Amsterdam […]

News

IXAnext Physics2Market grant and invitation to Round Table discussion for Chris Slootweg

Chris Slootweg (UvA) has been awarded an IXAnext Physics2Market grant for his work to use sodium borohydride as a carrier of hydrogen. For his expertise on the energy transition, especially in the field of hydrogen Slootweg has been invited to participate in the round-table discussion on the energy transition.  Regeneration protocol to release hydrogen Hydrogen […]

News

Rewarded Take-off grants for Amsterdam projects

Various projects within the Amsterdam knowledge institutions have received funding through a Take-off program from NWO. With this funding, they can further investigate the market opportunities for their products through a feasibility study or with an early stage route. Projects Feasibility studies (phase 1) VU-AMS, Ambulatory Monitoring of the Autonomic Nervous System Hoofdaanvrager: Prof. dr. […]

News

LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy

LUMICKS has entered into a collaboration with Glycostem Therapeutics, the Netherlands, to improve immunotherapeutic drug development. By quantifying binding strength between immune and cancer cells using the unique z-Movi® Cell Avidity Analyzer, Glycostem exploits the predictiveness of avidity in finding the best NK-cell population for cellular therapy. Glycostem is a leading NK-cell manufacturer that has […]

News

Intravacc to in-license CimCure’s iBoost technology, expanding its vaccine platform portfolio

CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]

News